<qa>  Patients with clinical progression due to prostate cancer must meet study exclusion criteria to be allowed to crossPatients with clinical progression due to prostate cancer must meet study exclusion criteria to be permitted to cross-over to the opposite treatment. Patients with clinical progression due to pain from prostate cancer are not permitted to cross-over. 